- Liau, Linda;
- Weiss, William;
- Remke, M;
- Ramaswamy, V;
- Peacock, J;
- Shih, DJH;
- Koelsche, C;
- Northcott, PA;
- Hill, N;
- Cavalli, FMG;
- Kool, M;
- Wang, X
Telomerase reverse transcriptase (TERT) promoter mutations were recently shown to drive telomerase activity in various cancer types, including medulloblastoma. However, the clinical and biological implications of TERT mutations in medulloblastoma have not
